Document:

entl-ex1014_1080.htm

Exhibit 10.14

Entellus Medical, Inc.

Non-Employee Director Compensation Program

 

Effective January 9, 2016

 

This Entellus Medical, Inc. (the “Company”) Non-Employee Director Compensation Program (this “Program”) for non-employee directors (the “Directors”) of the board of directors of the Company (the “Board”) shall be effective on the date set forth above (the “Effective Date”).  Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Entellus Medical, Inc. 2015 Incentive Award Plan (the “Plan”).  The original Program was effective upon the closing of the Company’s initial public offering of its common stock (the “Original Effective Date”).

 

Cash Compensation

 

Effective upon the Effective Date, Directors will become entitled to receive annual retainers in the following amounts, pro-rated for any partial year of service:

 

		
	
Director:
	
$35,000

	
Chairman:
	
$40,000

	
Chair of Audit Committee:
	
$20,000

	
Chair of Compensation Committee:
	
$15,000

	
Chair of Nominating and Corporate Governance Committee:
	
$10,000

	
Audit Committee Member (Non-Chair):
	
$10,000

	
Compensation Committee Member (Non-Chair):
	
$7,500

	
Nominating and Corporate Governance Committee (Non-Chair):
	
$5,000

	
 

All annual retainers will be paid in cash quarterly in arrears promptly following the end of the applicable calendar quarter, but in no event more than thirty (30) days after the end of such quarter.   For the avoidance of doubt, no Director will receive any annual retainer (or portion thereof) with respect to services provided to the Company prior to the Original Effective Date.

 

Equity Compensation

 

		

 

 

		
	
Initial Stock Option Grant:
	
Each Director who is initially elected or appointed to serve on the Board upon or after the Original Effective Date is hereby granted an Option to purchase 15,000 Shares under the Plan or any other applicable Company equity incentive plan then-maintained by the Company (the “Initial Option”).  

 

The Initial Option is hereby granted on the date on which such 

Director is initially elected or appointed to serve on the Board (the “Election Date”), and shall vest with respect to 1/12th  of the Shares subject thereto on each quarterly anniversary of the applicable Election Date occurring over the three-year period immediately following the applicable Election Date, subject to continued service through the applicable vesting date.  

 

Each Initial Option shall have an exercise price per Share equal to the Fair Market Value of a Share on the applicable Election Date.

 

	
Annual Stock Option Grant:
	
Each Director serving on the Board as of the date of each annual shareholder meeting of the Company (each, an “Annual Meeting”) occurring after the Effective Date shall be granted an Option to purchase 10,000 shares of Common Stock under the Plan or any other applicable Company equity incentive plan then-maintained by the Company (the “Annual Option”).  

 

The Annual Option will be granted on the date of the applicable Annual Meeting, and will vest in full on the earlier to occur of (i) the first anniversary of the date of grant and (ii) the date of the Annual Meeting immediately following the date of grant, subject in each case to continued service through the applicable vesting date.

 

Each Annual Option shall have an exercise price per Share equal to the Fair Market Value of a Share on the date of the applicable Annual  Meeting.

 

Miscellaneous

 

Each Initial Option and each Annual Option shall be a Non-Qualified Stock Option and shall have a maximum term of ten years from the applicable date of grant.  All applicable terms of the Plan apply to this Program as if fully set forth herein, and all grants of Options are hereby subject in all respect to the terms of the Plan.  The grant of any Option under this Program shall be made solely by and subject to the terms set forth in a written Award Agreement in a form approved by the Board and duly executed by an executive officer of the Company.

 

Effectiveness, Amendment, Modification and Termination

 

This Program shall become effective upon the Effective Date.  This Program may be amended, modified or terminated by the Board in the future at its sole discretion.  No Director shall have any rights hereunder, except with respect to any Options actually granted pursuant to the Program.entl-ex1017_1078.htm

Exhibit 10.17

REVISED OFFER 

 

September 4, 2015 

 

 

Jeff Kogl

 

Dear Jeff,    

 

On behalf of Entellus Medical, I am pleased to extend to you an offer for employment as a Vice President of Business Development and Strategy directly reporting to me. You bring a skill set to this company that is essential to achieving our goals and I look forward to your contributions. 

 

In this exempt, full-time position with Entellus you will be paid an annual salary of $275,000.00 payable in accordance with the company’s standard payroll policies (currently semi-monthly). You will also be eligible through the Entellus bonus program to earn a pro-rated bonus which has a target of 35% of your base salary.  

 

We have also agreed to a one-time signing bonus of $40,000, payable on the first available payroll following your start date.  In the event you decide to voluntarily terminate your employment without good reason or Entellus terminates your employment due to performance within your first twelve months of employment, the signing bonus shall be repayable to the company on a pro-rated basis and deducted from your final paycheck.  

You will also be eligible for a 6 month severance package in accordance with our standard Vice President Plan.  Furthers details will be provided after your start date. 

 

You are also eligible for the benefit programs by Entellus Medical including medical, dental, life, disability, 401k, PTO, and paid holidays. All of this information will be reviewed with you during New Hire Orientation on your first day of employment.  Personal-Time-Off (PTO) will accrue monthly at a rate of 20 days per year.

 

Subject to board approval, you will also be granted a stock option for 100,000 shares at a price to be determined, by the Board, pursuant to a separate Stock Option Agreement that will be prepared after your first day of employment. The shares will vest over four years and are subject to a 1 year 25% cliff vesting.  The remaining options will vest on a monthly basis over the remaining 36 months of the agreement.  These options may be exercised up to 10 years from the date of grant, so long as you are a full-time employee of the company. 

 

Enclosed you will find our standard Inventions Assignment, Confidentiality and Non-Competition Agreement which we would ask you to review carefully.  Please execute and return this Agreement to Debbie Kahl, Director of Human Resources, at your earliest convenience.  The agreement is required to be signed prior to your first day of employment, as the offer is contingent upon execution of the Agreement.

 

Our offer is also contingent upon the successful completion of a criminal background check.  After accepting our offer details will be sent to you on our background check process. If any adverse information is discovered through the background check process Debbie will be in touch with you to discuss steps you will need to take.

 

 

 

Your employment with Entellus Medical will be “at-will.”  This means that you may terminate the employment relationship at any time for any reason, with or without prior notice, and that Entellus retains the same right.  No contract of employment other than “at-will” is expressed or implied, either by this offer or by any oral or written statements made prior or after this offer.  

 

This written offer of employment constitutes the entire understanding of the parties, supersedes all prior discussions, representations and understandings.  

 

 

All of us at Entellus Medical look forward to you joining our team and the future contributions you will make to the organization. 

 

 

Sincerely, 

 

/s/ Robert S. White        

Robert S. White 

President & CEO

 

 

I accept Entellus Medical Inc.’s offer of employment and acknowledge the terms and conditions of employment.

 

 

 

Accepted by:   /s/ Jeff KoglDate:10/22/2015       

 

Start date:     10/27/2015entl-ex1021_1079.htm

Exhibit 10.21

February 11, 2016

 

Brian E. Farley

3600 Holly Lane North, Suite 40

Plymouth, Minnesota 55447

 

Dear Brian:

 

On March 24, 2010 you were granted a non-statutory stock option (the “Option”) with respect to 489,500 shares of common stock of Entellus Medical, Inc. (the “Company”) (on a post-split basis) pursuant to a Non-Statutory Stock Option Agreement (the “Agreement”) and the Company’s 2006 Stock Incentive Plan (as Amended and Restated November 12, 2009, as amended) (the “Plan”).  This letter is to advise you that the Board of Directors has amended certain terms and provisions in the Agreement, effective as of January 9, 2016 (the “Effective Date”).

As of the Effective Date, Section 4 of your Agreement is amended to provide that all references to your “employment” shall instead refer to your “services”, such that any post-termination exercise windows will be based on a termination of services (rather than a termination of employment).  

Notwithstanding the foregoing, in no event may the Option be exercised after the expiration of its term which is ten (10) years from the dated of grant.

Your consent is not required for this amendment to your Agreement to become effective.  

 

 

Sincerely,

 

 

 

 

		
	
By:
	
/s/ Robert S. White

	
Name:
	
Robert S. White

	
Title:
	
Chief Executive Officer and PresidentCONSULTING
AGREEMENT

 

This
Agreement (the “Agreement”) is entered into as of 18th of June 2015 by and between Nova Smart Solutions Inc.
(“NOVA”) and its subsidiaries, and Abraham Domínguez Cinta (the “Consultant”).

 

Whereas,
NOVA is in the business of technological smart solutions and specializes in Corporate Solutions, Aviation, Natural Resources
and Security Systems;

 

Whereas,
the Consultant is experienced in public markets listing, structuring and development and NOVA wishes to retain his services.

 

Whereas,
NOVA desires to retain the Consultant to provide executive business advise to take advantage of the Consultant’s experience
and to exploit commercial opportunities, and the Consultant is willing to provide such consulting services acting on behalf of
NOVA.

 

Now
therefore, In consideration of the mutual covenants and promises contained herein, the parties hereto agree as follows:

 

1. Engagement;
Consultant Relationship; Duties; Title. NOVA hereby engages the Consultant, and the Consultant hereby agrees to render,
consulting services to NOVA in connection the management of the business. The Consultant shall devote a portion of his business
time and efforts to the public markets listing of NOVA. The Consultant shall use reasonable efforts in such endeavors. The Consultant
shall also perform the services with a level of care, skill, and diligence that a prudent professional acting in a like capacity
and familiar with such matters would use, and shall agree to abide by the rules of governance established by NOVA’s board
of directors.

 

Consultant
shall provide services as an Advisor to the CEO of NOVA or such other services for and on behalf of NOVA, through one or more
of its duly-authorized officers, may assign to Consultant from time to time, provided however, that Consultant will not be unreasonably
assigned to any function that does not have comparable status, level of responsibilities and duties as the position initially
assumed under this Agreement. Consultant shall perform such services and duties for NOVA as are usually and customarily required
of a person holding the position of Advisor to the CEO (or other position as assigned by NOVA) in the industry in which NOVA does
business.

 

    	 	1	 

    	 

    

Consultant
shall promptly obey, comply with and be subject to all rules, regulations and orders that may from time to time be issued by NOVA
and that are in keeping with Consultant’s relation with NOVA and such rules, regulations and orders shall have the same
force and effect as though they were written into this Agreement at this time, including without limitation Buyer's code of business
conduct & ethics policies, insider trading policies, and confidentiality requirements. The services to be performed by Consultant
shall be principally rendered in the U.S. (“Consultant’s Principal Place of Business”), together with such business
travel as may be necessary for Consultant to satisfactorily perform the duties required under this Agreement. Consultant shall
report directly to the Board of Directors and/or President of NOVA.

 

2. Term
and Termination. The term of this Agreement shall begin on the date first signed and shall continue until the
completion of one year (the ‘Termination Date’) unless terminated by either party as described herein (the
“Term”). Prior to the Termination Date, NOVA may terminate this agreement for cause (defined as immoral,
unethical, or illegal behavior the Consultant) without prior notice. Should NOVA terminate this agreement other than for
cause, it shall provide the Consultant with 5 days’ notice.

 

Should
the Consultant terminate this agreement other than due to a breach of this Agreement by NOVA, Consultant shall forfeit any claims
to compensation for transactions completed by NOVA following the termination date, unless the fees earned were for work completed
by the Consultant prior to the termination date. Should NOVA terminate this agreement other than for a breach of this agreement,
it shall provide NOVA with 5 days’ notice.

 

3. Compensation. As
initial compensation for services rendered by the Consultant under this Agreement, NOVA shall issue the Consultant 1,000,000 shares
of NOVA’s common stock, upon the signing of this Agreement or another day agreed by the parties, and a retainer equal to
the estimated number of hours Consultant is to spend in the first 90 days of this Agreement, multiplied by the hourly rate specified
in Appendix A (“Consulting Rate”). The 1,000,000 shares of common stock issued shall be newly issued common shares.
Upon completion of any of the business development initiatives such as are listed on Schedule A, NOVA shall pay the Consultant
an incentive fee based on an agreed percentage of the value of the successful implementation of the initiatives, as further stipulated
on Schedule A, less any retainer fees paid.

    	 	2	 

    	 

    

 

NOVA
shall have exclusive right to nominate any incentive fee payments earned to be paid either in cash, or registered or restrictive
shares of common stock of NOVA at market price, or a mix thereof.

 

The
Consultant will also be eligible to participate in NOVA’s Incentive Stock Option Plan, as adopted by its Board of Directors,
and Consultant shall be entitled to participate in a manner consistent with other consultants to NOVA.

 

Unless
otherwise required by law, all such compensation shall be payable without deduction for national or local income taxes, social
security or any other amounts, which shall remain the responsibility of the Consultant.

 

4. Expenses. The
Consultant shall pay for his own expenses unless otherwise agreed or required by NOVA and pre-approved.

 

5. Independent
Contractor. The Consultant is an independent contractor providing services to NOVA. The Consultant is not an agent
of NOVA and shall have no right to bind NOVA, except as expressly and duly authorized by affirmative action of the CEO or board
of directors. NOVA, as appropriate, will report all payments to be made hereunder on Forms 1099 (or their equivalent in a different
country) as payments to the Consultant for independent contracting services. NOVA shall not carry worker’s compensation
insurance to cover the Consultant. NOVA shall not pay any contributions to Social Security, unemployment insurance, federal or
state withholding taxes, or their equivalent in another country, nor provide any other contributions or benefits that might be
expected in an employer-employee relationship.

 

6. No
Assignment. Unless otherwise agreed with NOVA, the Consultant shall not subcontract his duties or cause any other
person or entity to perform his services. The Consultant shall therefore not voluntarily or by operation of law assign or otherwise
transfer the obligations incurred on his part pursuant to the terms of this Agreement without the prior written consent of NOVA.
Any attempted assignment or transfer by Consultant of his obligations without such consent shall be voided.

 

7. Payment
of Fees. Consultant may instruct NOVA, in writing, to make payments earned under this Agreement to any other company
or individual as full and absolute settlement of such fees so long as doing so conforms to appropriate statutes, including without
limitation US or international tax law, the Patriot Act or other such legislation, and SEC regulations.

 

    	 	3	 

    	 

    

 

8. Confidentiality,
Non-Competition and Non-Circumvention. During the term of this Agreement and for a period of two (2) years after,
NOVA and Consultant agree that neither of them, nor any affiliate of them, directly or indirectly, or in any other capacity,
will (i) in any manner influence any person who is an employee of the other Party to leave such service or hire any such
person, (ii) contact or solicit any Person that is or at any time within the one year period immediately prior to the
date of this Agreement was a customer of NOVA or Consultant for the purpose of providing products, services or business
competitive with that provided by the other PARTY, or provide any such products, services or business to any such Person,
(iii) request or advise any suppliers, customers or accounts of the other Party to withdraw, curtail or cancel any
business that is placed with the other Party, (iv) use or disclose, or cause to be used or disclosed, any
secret, confidential or proprietary information of either Party, which is stipulated by either Party as confidential,
regardless of the fact that NOVA and/or Consultant or any NOVA Affiliate may have participated in the development of that
information, or (v) make any disparaging remarks about the other Party, their employees or officers, or their services,
practices or conduct.

 

9. Contracts
or Other Agreements with Current or Former Employer or Business. The Consultant hereby represents and warrants that he
is not subject to any agreement with respect to which the Consultant’s engagement by NOVA would be a breach.

 

10. Modification
of Agreement. This Agreement may be modified by the parties hereto only by a written supplemental agreement executed
by both parties.

 

11. Notice. All
notices and other communications required or permitted under this Agreement shall be in writing and, if mailed by prepaid first-class
mail or certified mail, return receipt requested, shall be deemed to have been received on the earlier of the date shown on the
receipt or three (3) business days after the postmarked date thereof. In addition, notices hereunder may be delivered by
hand, facsimile transmission or overnight courier, in which event the notice shall be deemed effective when delivered or transmitted.

 

12. Waiver
of Breach. The waiver by either party of any breach of any provision of this Agreement shall not operate or be construed
as a waiver of any subsequent breach.

 

13. Entire
Agreement. This Agreement contains the entire agreement of the parties relating to the subject matter of this Agreement
and supersedes any prior written or oral arrangements with respect to the Consultant’s engagement by NOVA.

 

    	 	4	 

    	 

    

 

14. Successors,
Binding Agreement. Subject to the restrictions on assignment contained herein, this Agreement shall inure to the
benefit of and be enforceable by NOVA’s successors and assigns.

 

15. Validity. The
invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement, which shall remain in full force and effect.

 

16. Survival
of Obligations. The duties and obligations contained in Paragraphs 6, 12, 13, 15 and 17 shall survive the expiration
or termination of this Agreement.

 

17. Multiple
Counterparts. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed
an original, but all of which shall together constitute one and the same Agreement.

 

18. Tax
Withholding; Indemnification. By reason of Consultant’s relationship with NOVA as an independent contractor, all
sums required to be paid by NOVA to Consultant shall be paid in full, without reduction for any withholding taxes, employers’
taxes, social security taxes, payments or contributions, and similar employer withholdings, deductions and payments. Consultant
acknowledges and agrees that Consultant shall be solely responsible for making all such filings and payments and shall indemnify
and hold harmless NOVA for any liability, claim, expense or other cost incurred by NOVA arising out of or related to the obligations
of Consultant pursuant to this Paragraph 16.

 

19. Applicable
Law. This Agreement shall be governed by and construed in accordance with the domestic laws of the State of Florida.

 

20. Headings. The
headings of the Paragraphs of this Agreement are for convenience only and shall not control or affect the meaning or construction
or limit the scope or intent of any of the provisions of this Agreement.

 

 

 

[Signature
Page Follows]

    	 	5	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed, or cause their duly assigned agent to execute, this Agreement as of the date
first set forth above.

 

	For Nova Smart Solutions Inc.	 	Consultant
	 	 	 
	/s/ Sergio Camarero Blanco	 	 /s/ Abraham Domínguez Cinta
	Sergio Camarero Blanco, CEO	 	Abraham Domínguez Cinta
	 	 	 

    	 	6	 

    	 

    

Schedule
A

 

 

Compensation
for Business Development Initiatives of the Consultant

 

1.Sales
of NOVA Services or Products 

 

Incentive
Fee payable: For gross margin (sales less all direct costs of sales) received and paid to NOVA for products or services sourced
by the Consultant: 50% of the first $10,000 in any given month; plus 25% of the amount above $10,000, until $15,000 in cash compensation
in any given month is achieved; and thereafter 10%.

 

2.New
Contracts of business for services to be rendered by NOVA 

 

Incentive
Fee payable: 2% of the first year value of the contract, based on gross revenues of any related business to NOVA, as determined
by NOVA’s auditors. This amount shall be on top of the payments in #1 above.

 

3.Hiring
of key executives introduced to NOVA by the Consultant 

 

Incentive
Fee payable: $15,000 for any senior executive (director or vice president), and $5,000 for any other management employee hired
by NOVA, payable in cash or shares of NOVA common stock.

 

4.Acquisition

 

Incentive
Fee payable: Compensation in the form of common shares will be issued to the Consultant for any company or part of a company
that NOVA acquires that the Consultant sourced and introduced to NOVA and which was subsequently acquired. For deals above $75
million, compensation shall be equivalent to 1% of the value of the transaction; 5% for deals under the value of $10 million and
3% for deals in between.

 

5.Consulting
and Advising 

 

An
hourly fee of $120 (“Consulting Rate”) or pre-negotiated fixed fee will be paid for NOVA approved activities to provide
consulting and advisory services to NOVA. Consultant must provide regular written status reports and invoices.

    	 	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}]]